Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jan 6;16(1):e0243536. doi: 10.1371/journal.pone.0243536

Prevalence, causes and impact of musculoskeletal impairment in Malawi: A national cluster randomized survey

Leonard Banza Ngoie 1,2,*, Eva Dybvik 3, Geir Hallan 1,2,3,4, Jan-Erik Gjertsen 1,2,4, Nyengo Mkandawire 5,6, Carlos Varela 1,2,5, Sven Young 1,2,4,5,7
Editor: Subas Neupane8
PMCID: PMC7787380  PMID: 33406087

Abstract

Background

There is a lack of accurate information on the prevalence and causes of musculoskeletal impairment (MSI) in low income countries. The WHO prevalence estimate does not help plan services for specific national income levels or countries. The aim of this study was to find the prevalence, impact, causes and factors associated with musculoskeletal impairment in Malawi. We wished to undertake a national cluster randomized survey of musculoskeletal impairment in Malawi, one of the UN Least Developed Countries (LDC), that involved a reliable sampling methodology with a case definition and diagnostic criteria that could clearly be related to the classification system used in the WHO International Classification of Functioning, Disability and Health (ICF)

Methods

A sample size of 1,481 households was calculated using data from the latest national census and an expected prevalence based on similar surveys conducted in Rwanda and Cameroon. We randomly selected clusters across the whole country through probability proportional to size sampling with an urban/rural and demographic split that matched the distribution of the population. In the field, randomization of households in a cluster was based on a ground bottle spin. All household members present were screened, and all MSI cases identified were examined in more detail by medical students under supervision, using a standardized interview and examination protocol. Data collection was carried out from 1st July to 30th August 2016. Extrapolation was done based on study size compared to the population of Malawi. MSI severity was classified using the parameters for the percentage of function outlined in the WHO International Classification of Functioning (ICF). A loss of function of 5–24% was mild, 25–49% was moderate and 50–90% was severe. The Malawian version of the EQ-5D-3L questionnaire was used, and EQ-5D index scores were calculated using population values from Zimbabwe, as a population value set for Malawi is not currently available. Chi-square test was used to test categorical variables. Odds ratio (OR) was calculated with a linear regression model adjusted for age, gender, location and education.

Results

A total of 8,801 individuals were enumerated in 1,481 households. Of the 8,548 participants that were screened and examined (response rate of 97.1%), 810 cases of MSI were diagnosed of which 18% (108) had mild, 54% (329) had moderate and 28% (167) had severe MSI as classified by ICF. There was an overall prevalence of MSI of 9.5% (CI 8.9–10.1). The prevalence of MSI increased with age, and was similar in men (9.3%) and women (9.6%). People without formal education were more likely to have MSI [13.3% (CI 11.8–14.8)] compared to those with formal education levels [8.9% (CI 8.1–9.7), p<0.001] for primary school and [5.9% (4.6–7.2), p<0.001] for secondary school. Overall, 33.2% of MSIs were due to congenital causes, 25.6% were neurological in origin, 19.2% due to acquired non-traumatic non-infective causes, 16.8% due to trauma and 5.2% due to infection. Extrapolation of these findings indicated that there are approximately one million cases of MSI in Malawi that need further treatment. MSI had a profound impact on quality of life. Analysis of disaggregated quality of life measures using EQ-5D showed clear correlation with the ICF class. A large proportion of patients with moderate and severe MSI were confined to bed, unable to wash or undress or unable to perform usual daily activities.

Conclusion

This study has uncovered a high prevalence of MSI in Malawi and its profound impact on a large proportion of the population. These findings suggest that MSI places a considerable strain on social and financial structures in this low-income country. The Quality of Life of those with severe MSI is considerably affected. The huge burden of musculoskeletal impairment in Malawi is mostly unattended, revealing an urgent need to scale up surgical and rehabilitation services in the country.

Introduction

Musculoskeletal disease is one of the major causes of physical disability globally, yet data regarding the magnitude of this burden in developing countries is lacking [1]. One reason for this is the absence of a universal understanding of the definition of physical disability. The difficulty in defining physical disability stems from its many anatomical, physiological and pathological presentations and causes, and its intimate relation to society and the environment [2]. There have been many attempts to reach a common understanding of disability, and the World Health Organization’s (WHO) publication of the International Classification of Functioning, Disability and Health (ICF) is a major step forward. The ICF classifies impairment of body structure and function, and also includes domains that measure activity and participation in society. Musculoskeletal impairment (MSI) is according to the ICF defined as “…a lack of normal structure or function, or an increase in pain or discomfort in the integument, muscles, bone or joints of the body of an individual, that has lasted at least 1 month and which limits function of the musculoskeletal system…” [2].

The UN Convention on the Rights of Persons with Disabilities (UNCRPD) defines disability as “long-term physical, mental, intellectual or sensory impairments which, in interaction with various barriers, may hinder [a person’s] full and effective participation in society on an equal basis with other” [3].

There is also a lack of accurate information on the prevalence and causes of physical disability due to the lack of surveys in low-income countries (LICs) [4, 5]. The WHO estimates that the prevalence of all types of disability on a global level is around 10% [6], but this estimate does not help plan services in specific situations or countries. Realizing the challenge, Helander developed a ‘Rapid Calculation of Disability Prevalence’ for less developed regions of the world and estimated that 4.8% of a population will need some rehabilitation service [7].

Musculoskeletal disease encompasses a wide range of conditions resulting from various etiologies such as traumatic, infectious, inflammatory, metabolic, congenital, developmental and degenerative condition; many of which benefit from surgical interventions. Musculoskeletal disease is an important cause of morbidity and mortality, especially in LICs [8], affecting a large portion of the world’s population in one form or another, with non-traumatic musculoskeletal disease estimated to account for 6.8% of all Disability-Adjusted Life Years (DALY) lost [1]. Most road injuries are musculoskeletal in nature [9], and several studies have shown the heavy burden of musculoskeletal injuries in Low and Middle Income Countries (LMICs) [10, 11]. For each person who dies from trauma, three to eight more are permanently disabled [12, 13]. Estimates from a nationwide survey in Rwanda suggested a prevalence of musculoskeletal impairment of 5.2% [8]. A similar study in Fundong district, North-West Cameroon found a prevalence of 11.2% [14, 15]. Data on the prevalence of MSI in Malawi is scarce.

There have been several surveys of physical disability in Malawi in the past [16, 17]. However, these studies have targeted small cohorts of the population and focused on disability in general, which may have led to an underestimation of the burden of MSI in the community in general. None of these previous studies has evaluated the quality of life among people with MSI. Therefore, it is imperative to use a survey methodology to estimate the prevalence of MSI in Malawi that can be extrapolated on a national level and compared to data from other countries. This data is needed for informing policy development, service delivery, and evidence-based advocacy for people with MSI in Malawi.

In view of the lack of accurate data on the prevalence and causes of MSI in Malawi, we conducted a survey of MSI using a reliable sampling methodology with a case definition and diagnostic criteria that could clearly be related to the classification system used in the ICF. The aim of this study was to assess to report the prevalence, impact, causes and service implications of MSI in Malawi. Data gathered will inform policy on advocacy and lobbying for appropriate resource allocation for MSI. To achieve this we chose to use a new survey tool developed in Rwanda by Atijosan et al. (2007).

Methods

Setting

Malawi has an estimated population of about 18.3 million (Nation estimates 2018 census). The country is divided in 3 administrative regions: The Northern, Central, and Southern Regions. The Central and Southern regions are the most densely populated with 6.4 and 6.8 million respectively [18]. Malawi has 28 districts and a total of 48,233 registered settlements. The vast majority of these are in the rural areas. About 90% of the population live in rural areas and are dependent mostly on subsistence farming [19].

Sample selection

A sample size of 1,481 households was derived based on the following formula for calculation of household sample sizes:—nh = (84.5)(1-r)/(r)(p) [20] and assuming 95 percent level of confidence, a sample design effect of 2.0, a non-response multiplier of 1.1, an average household size of 6, and a margin of error of 10%. Based on estimates from Rwanda and Cameroon, r (a key indicator to be measured by the survey, being prevalence of musculoskeletal impairment for this study) is 5.4% [4] and since all the population will be targeted, p = 1. The formula therefore gives a sample size of n = (84.5)(1–0.054)/(0.054)(1.0) = 1,481 households.

We selected clusters across the whole country through probability proportional to size sampling with an urban/rural and demographic split that matched the national distribution of the population. Then individuals (both adults and children) were examined in their households by survey field teams.

The National Statistics Office provided a list of enumeration areas from the Malawi Census Board for 2008 national census records. These settlements were randomized through computer-generated random numbers, selecting 55 settlements as enumeration areas from each district in Malawi for this survey. Two or four households were randomly selected in each settlement depending on size. The randomization was based on a ground bottle spin and selecting the third or fifth house in the direction of spin depending on the size of the settlement. Subsequently the bottle spinning was repeated after the household interview to select the next household in the new direction of the spin. The next thirds household was then picked if in a smaller settlement, or fifth household if in a larger settlement, then repeating the process again to select the next household. All household members present were screened. For the youngest (age below five) household members, the guardian of the child was interviewed. People were eligible for inclusion if they lived in the household at least three months of the year. All the individuals in the final household were interviewed, and the number of people needed to complete the survey in the settlement was randomly selected for inclusion (e.g. if the final household included six people but only two were required to complete the number for the settlement then two out of the six were randomly selected for inclusion). If an eligible participant was absent the survey team paid one more visit to the household to examine him/her before leaving the area. If not found, information about his/her presumed MSI status was collected from relatives present.

Musculoskeletal impairment assessment

The survey tool developed in Rwanda by Atijosan et al. (2007) fulfilled the proposed criteria and aims, and was therefore chosen for this study [21]. This screening tool was developed by orthopaedic surgeons together with physiotherapists and has been shown to have 99% sensitivity and 97% specificity with inter-observer Kappa scores of 0.90 for the diagnostic group. The team of data collectors screened all participants for MSI by asking them seven questions about difficulties using their musculoskeletal system and how long they had had these symptoms. Participants who answered ‘‘yes” to any of the questions were classified as cases, provided that the condition had lasted for more than one month or was considered permanent (Table 1). The questionnaire and other Rapid Assessment of Musculoskeletal Impairment (RAM 1& RAM 2) were installed on 17 tablet computers (iPad 2, Apple Inc.), using File Maker Pro 12.0v3 (File maker Inc., USA) software for data collection in English (see Appendix of S1 and S2 Files).

Table 1. Screening questionnaire.

Screening for musculoskeletal impairment Yes No
1. Is any part of your body missing or misshapen?
2. Do you have any difficulty using your arms?
3. Do you have any difficulty using your legs?
4. Do you have any difficulty using any other part of your body?
5. Do you need a mobility aid or prosthesis?
6. Do you have convulsions, involuntary movement, rigidity or loss of consciousness?
If any of the answers are "yes”:
7. Has it lasted more than one month or is it permanent?

The fieldworkers visited households door-to-door and conducted the MSI screening in the household. The survey team was assisted in the village by a village guide, appointed by the village leaders. The purpose of the study and the examination procedure were explained to the subjects and verbal consent was obtained before examination.

Screening for musculoskeletal impairment

Standardized interview and examination protocol

All cases were examined in more detail by the students using a standardized interview and physical examination protocol. Whenever in doubt, the students consulted a supervisor physically or by phone (calls or pictures). Only those who were able to respond to all the five dimensions of quality of life (EQ-5D-3L) were eligible.

The standardized examination protocol assessed the area affected, duration, etiology, diagnosis, severity, quality of life of the participants and treatment received and needed. The elements included in the interview and examination protocol are presented in Table 2

Table 2. Standardized interview and examination protocol.
Elements Definition
Physical assessment Performance of physical tasks that require use of the musculoskeletal system, both lower and upper limb motor skills. (i.e. walking, standing, sitting, running etc.)
Anatomical location Information of the affected part of the body (e.g. leg) and the nature of the problem (e.g. tumour)
Duration The duration of the MSI, classified into a long (> 1 month) or short (<1 month) standing history
Etiology Initiation and cause of the impairment (infection, violence etc.)
Diagnosis Diagnosis categorized as: neurological, traumatic, congenital, metabolic, infective, or acquired non-traumatic non-infective. Within these categories an algorithm was created and used to give a specific diagnosis. Up to two diagnoses were permissible per case [21].
Severity Severity was classified as ‘‘mild”, ‘‘moderate” or ‘‘severe according to ICF “[22].
Quality of life (EQ-5D) The Malawian version of the EQ-5D-3L questionnaire [23].
Treatment received Any known treatment given to the participant (medical or others) was recorded
Treatment needed Treatment required by the participants was assessed according to Malawi standard treatment guideline
Barriers to treatment Participants were asked one question about why they had not received treatment for their MSI. All responses (up to four options) were recorded on pre-coded forms

Quality of life: The EQ-5D-3L is a public domain quality of life questionnaire from the Euro-Qol group, which has been validated in a number of countries and cultural settings [24]. It allows the participant to indicate their health state by indicating the most applicable statement in five parameters, including mobility, self-care, usual activities, pain/discomfort, anxiety/depression, with a maximum score of 100 (best quality of life) and minimum score of 0 (death). Severity was determined using the parameters for the percentage of function outlined in the WHO reference book International Classification of Functioning (ICF) [2]. A loss of function of 5–24% was mild, 25–49% was moderate and 50–90% was severe. The Malawian version of the EQ-5D-3L questionnaire was used [23]

Data collection

Data collection was done by 32 third-year medical students. They all underwent a 14 days training supervised by two orthopaedic surgeons and two senior orthopaedic clinical officers on how to assess persons with musculoskeletal impairment and the use of the questionnaire and computer tablet. A pilot study/training was carried out in rural areas of the capital city, Lilongwe. The aim was to assess the examination process, function of the computer tablets and procedures. A second round of training was carried out as a refresher after the pilot study in preparation for the national survey.

Data were collected from 1st July to 30th August 2016. In some areas, local translators were hired to secure good communication between the interviewer and the household member. Each data collector covered approximately two households per day (10–12 participants), therefore 30–34 households were interviewed every day. Interviews took place in the interviewees’ private homes. Data was checked and exported into the Excel (Microsoft 2010) pooled database at the end of each day, for data security and to assure the quality of the data collection [18]. A survey record was filled in for each eligible person that included: Demographic information (all participants), screening examination for MSI, a standardized interview and examination protocol for MSI, history of MSI (if not examined).

Statistical analysis

Extrapolation was done based on study size compared to the population of Malawi. Chi-square test was used to test categorical variables. Odds ratio (OR) was calculated with a linear regression model adjusted for age, gender, location and education. EQ-5D index scores were calculated using the values from Zimbabwe [25, 26], as there are no values for Malawi, and Zimbabwe was considered the closest country. The statistical analyses were performed using IMB-SPSS Statistics, version 24.0 for Windows (IBM Corp, Armonk, NY, USA) and the statistical package R, version 3.4.0 (http://www.R-project.org). P-values less than 0.05 were considered statistically significant.

Ethical approval

The approval to conduct this survey was granted by the College of Medicine Research and Ethics Committee (COMREC) and The Regional Committee for Medical and Health Research Ethics (REC Western Norway) in Norway. Consent to survey the districts and clusters were granted respectively by the District Commissioner and village head for each visited district and cluster.

Consent was obtained from the participants after explaining to them the goals and possible benefits of the study. Both verbal and written consent were obtained from adults (18 years of age and above), and assent were obtained from parents/guardians of children less than 18 years of age.

Data collectors were allowed to take photographs for teaching and discussion purposes after a verbal consent was granted from the participant. All those with manageable MSI were referred either to the MACOHA (Malawi Council of Handicapped) field workers (in the central region) or to district hospitals in the northern and southern region of Malawi for appropriate action such as Physiotherapy, prosthetic and orthotic devices, mobility aids and orthopaedic surgery.

This study was funded by Norad through the Norhed programme.

Results

The total number of included households was 1,481, with a total of 8,886 persons enumerated (with an average household size of six). 85 participants were excluded due to missing data. Among the 8,801 persons properly enumerated, 16 participants were not able to communicate (adequately), 64 refused to participate, and 173 were absent. Finally, 8,548 persons were screened or examined (response rate of 97.1%). The response rate was similar in women (97.5%) and men (96.7%). Among the participants that were enumerated, but not examined, eight (3.2%) were believed to have MSI. The age and gender distribution of the sampled population was similar to that of the national population (Table 3). During the national population and housing census enumeration process, the enumerators estimate the age of persons with unknown age based on past events or events of national interest (Nation estimates 2008 census).

Table 3. Age and gender composition of national and screened sample population.

Age groups Male Female Total
National Enumerated Sample (%) Screened Sample (%) National Enumerated Sample (%) Screened Sample (%) National Enumerated Sample (%) Screened Sample (%)
0–10 3,282,887 1,163 (26.7%) 1,132 (26.8%) 3,197,698 1,050 (23.7%) 1,033 (23.9%) 6,480,585 2,213 (25.1%) 2,165 (25.3%)
11–20 1,992,015 1,265 (29%) 1,217 (28.8%) 2,054,034 1,179 (26.6%) 1,131 (26.1%) 4,046,049 2,444 (27.8%) 2,348 (27.5%)
21–30 1,380,453 690 (15.8%) 660 (15.6%) 1,452,729 772 (17.4%) 755 (17.4%) 2,833,182 1,462 (16.6%) 1,415 (16.6%)
31–40 928,658 451 (10.3%) 441 (10.5%) 1,002,444 535 (12.1%) 526 (12.2%) 1,931,102 986 (11.2%) 967 (11.3%)
41–50 587,303 337 (7.7%) 330 (7.8%) 635,670 333 (7.5%) 325 (7.5%) 1,222,973 670 (7.6%) 655 (7.7%)
51–60 332,188 188 (4.3%) 182 (4.3%) 365,001 243 (5.5%) 237 (5.5%) 697,189 431 (4.9%) 419 (4.9%)
>60 326,567 239 (5.5%) 233 (5.5%) 393,988 317 (7.1%) 312 (7.2%) 720,555 556 (6.3%) 545 (6.4%)
Unknown* 29 (0.7%) 24 (0.6%) 10 (0.2%) 10 (0.2%) 39 (0.4%) 34 (0.4%)
Total 8,830,071 4,362 (100.0) 4,219 (100.0) 9,101,564 4,439 (100.0) 4,329 (100.0) 17,931,635 8,801 (100.0) 8,548 (100.0)

*participants with unknown age.

Prevalence of MSI

Of the 8,548 participants that were screened, 810 cases of MSI were diagnosed. This gave an overall prevalence of MSI of 9.5% (CI 8.9–10.1) (Table 2). The prevalence of MSI was higher among participants aged between 31 and 60 years (OR = 1.9, 1.5–2.5) and those over 60 years (OR = 5.7, 4.2–7.7) compared to the three youngest groups together (Fig 1). The prevalence of MSI was similar in men (9.3%) and women (9.6%). Persons without formal education were more likely to have an MSI (13.3%) compared to those with formal education levels (Table 4). The odds ratios were derived from logistic regression analyses (adjusted for age group, gender, location and education level).

Fig 1. Number and diagnostic categories of MSI, by age group.

Fig 1

Y-axis: Number of cases.

Table 4. Prevalence of MSI by age, gender, location and educational level of head of household.

Categories Total no Screened No of MSI cases Prevalence of MSI (95% CI) Age and gender adjusted Odds Ratios (95% CI)
Total 8,548 810 9.5 (8.9–10.1)
Age groups, years 0–5 1,109 76 6.9 (5.4–8.3) 1.0 (0.8–1.3)
6–16 2,539 160 6.3 (5.4–7.2) 0.9 (0.7–1.2)
17–30 2,280 154 6.8 (5.2–7.8) 1
31–60 2,041 254 12.4 (11.0–13.9) 2.0 (1.6–2.4)
>60 545 161 29.5 (25.7–33.4) 5.8 (4.5–7.4)
Unknown* 34 5 14.7 (2.8–26.6) 2.4 (0.9–6.2)
Gender Male 4,219 393 9.3 (8.4–10.2) 1
Female 4,329 417 9.6 (8.8–10.5) 1.0 (0.8–1.1)
Location Rural 8,058 773 9.6 (8.9–10.2) 1
Urban 415 33 8.0 (5.3–10.6) 0.9 (0.6–1.2)
Mobile, urban/rural 75 4 5.3 (0.2–10.4) 0.5 (0.2–1.4)
Education level of head of household** No formal education 2,074 276 13.3 (11.8–14.8) 1
Primary school 5,025 449 8.9 (8.1–9.7) 0.7 (0.6–0.8)
Secondary school 1,249 74 5.9 (4.6–7.2) 0.4 (0.3–0.6)
University / college 98 7 7.1 (2.0–12.2) 0.5 (0.2–1.0)
Unknown 102 4 3.9 (0.2–7.2) 0.3 (0.1–0.8)

* Participants with unknown age.

** The education number of the head of household accounted for each of the screened participants.

Prevalence of MSI by severity, and quality of life

MSI had an impact on the patients’ quality of life. Patients with severe MSI had lower quality of life compared to patients with mild MSI (Table 5). Table 6 shows that all 5 dimensions of the EQ-5D were influenced by the degree of MSI. Some 25–30% of patients with severe MSI were confined to bed, unable to wash or undress or unable to perform usual activities (Table 6). Further, a large proportion of patients with severe MSI had pain or anxiety/depression.

Table 5. Impact of MSI on quality of life.

MSI status Number Mean EQ-5D index score Std Error of the mean 95% CI
Mild MSI 108 81.6 1.63 78.4–84.8
Moderate MSI 329 69.4 0.98 67.4–71.3
Severe MSI 167 49.2 2.15 45.0–53.4
Total 604* 66.0 0.96 64.1–67.9

*Out of 810 cases of MSI, 604 participants were able to respond to all the five dimensions of the EQ-5D-3L.

Table 6. Distribution of patients in each level of the 5 dimensions of EQ-5D-3L according to MSI severity level.

EQ-5D Mild MSI Moderate MSI Severe MSI p-value*
Mobility
 • No problems in walking about
 • Some problems in walking about
 • Confined to bed

82 (64.1%)
44 (34.4%)
2 (1.6%)

117 (32.9%)
224 (62.9%)
15 (4.2%)

31 (16.6%)
110 (58.8%)
46 (24.6%)
<0.001
Self-care
 • No problems with self-care
 • Some problems with self-care
 • Unable to wash or dress

104 (82.5%)
19 (15.1%)
3 (2.4%)

211 (59.1%)
124 (34.7%)
22 (6.2%)

56 (31.1%)
77 (42.8%)
47 (26.1%)
<0.001
Usual activities
 • No problem in performing usual activities
 • Some problem in performing usual activities
 • Unable to perform usual activities

72 (63.7%)
40 (35.4%)
1 (0.9%)

105 (30.5%)
216 (62.8%)
23 (6.7%)

21 (12.1%)
98 (56.6%)
54 (31.2%)
<0.001
Pain/Discomfort
 • No pain or discomfort
 • Some pain or discomfort
 • Extreme pain or discomfort

64 (53.8%)
51 (42.9%)
4 (3.4%)

126 (35.6%)
206 (58.2%)
22 (6.2%)

63 (34.4%)
81 (44.3%)
39 (21.3%)
<0.001
Anxiety/Depression
 • Not anxious or depressed
 • Moderately anxious or depressed
 • Extremely anxious or depressed

82 (70.1%)
33 (28.2%)
2 (1.7%)

139 (40.3%)
185 (53.6%)
21 (6.1%)

45 (25.3%)
81 (45.5%)
52 (29.2%)
<0.001

* p-values were calculated using the Chi square.

MSI diagnoses

There were a total of 1,174 diagnoses for 810 individuals with MSI diagnosed (Table 7). Overall, 33.2% of MSIs were due to congenital causes, 25.6% were neurological in origin, 19.2% were acquired non-traumatic non-infective causes, 16.8% were due to trauma, and 5.2% due to infection. Congenital and neurological diagnoses remained relatively constant in all age groups. Acquired non-traumatic non-infective diagnoses were common in participants 31 years of age and above. However, trauma diagnoses were uncommon in participants 5 years of age and below.

Table 7. Cause of MSI in survey, and extrapolated to population of Malawi.

Diagnosis Number Total in category (%) Extrapolated number of that diagnosis in Malawi to nearest 1000
Congenital deformity 390 (33.2%) 818,000
Syndactyly 43
Polydactyly 74
Other Upper Limb deformity 32
Club foot 41
Other Lower Limb deformity 56
Spine deformity 125
Other congenital deformity 19
Trauma 198 (16.8%) 415,000
Burn contracture 24
Fracture non-/ malunion 48
Spine injury 1
Head injury 6
Tendon/nerve injury 45
Amputation 46
Joint chronic dislocation 21
Other chronic joint injury 7
Neurological 299 (25.6%) 627,000
Epilepsy 106
Polio (sequelae) 33
Para/quadra/Hemiplegia 61
Cerebral palsy 65
Peripheral nerve palsy 12
Other neurological MSI 22
Infective 62 (5.2%) 130,000
Bone infection limb 19
Joint infection 12
Spine infection 16
Soft tissue infection 15
Other acquired non-infective non- traumatic 225 (19.2%) 472,000
Angular limb deformity 24
Degenerative and other Joint problem 108
Spine pain 3
Skin/ soft tissue/ bone swelling 19
Limb swelling 57
Limb pain 6
Other acquired spine deformity 8
Total 1174

Treatment needed

In total, 503 treatments were needed for the 1,174 diagnoses (Table 8). The most common treatments needed were prosthetic and orthotic devices (33.1%), medication (26.6%), physical therapy (15%) and surgery (4%). Extrapolating these estimates to the entire population of Malawi, approximately 1,054,000 treatments are required, including 350,000 prosthetic and orthotic devices; 281,000 courses of medicine; 159,000 courses of physical therapy and 42,000 operations.

Table 8. Treatment needed among cases with MSI in survey and extrapolated to population of Malawi.

Treatment modality Number of cases in survey needing that treatment modality Extrapolated number in country needing that treatment modality (based on 2016 population estimates)
Medication 134 281,000
Physiotherapy 76 159,000
Appliance 36 75,000
Prosthesis 72 151,000
Orthosis (splints/braces) 95 199,000
Surgery 20 42,000
Wheelchair /Tricycle 39 82,000
Permanent care 6 3,000
None 25 52,000
Total 503

Discussion

The main findings of this study are the high estimated prevalence of MSI in Malawi of 9.5% (CI 8.9–10.1) and the need for over one million interventions including medication, physical therapy, prosthetic orthotic devices and surgery to alleviate the burden. Most cases of MSI were moderate (54%) or severe (28%) according to the ICF classification. These MSIs greatly affect people’s quality of life, having impact on all five dimensions of EQ-5D. The severity and scale of the burden of MSI in Malawi is likely to affect society at large [27, 28] and have a negative impact on the development of the communities and of Malawi as a country [27].

The factors that were associated with increased risk of MSI were increased age and lack of formal education. In the former, this was the result of an increase in acquired non-traumatic non-infective degenerative conditions. These results were in line with the findings reported in a similar study in Rwanda [8]. Another study on disability transitions and health expectancies among adults 45 years and older in Malawi has shown that the risks of experiencing functional limitations due to poor physical health are high in this population, and the onset of physical disabilities happens early in life [29]. Lack of education is likely to coincide with farming as an occupation, rural location, hard work and poor ergonomics that could to lead to MSI. There was a tendency towards more MSI in rural areas. But the low number of cases from urban areas could be due to the lower number of people living in the urban areas. However the prevalence of MSI was similar in men and women.

With regard to causes of MSI, congenital and neurological causes were the most common diagnostic categories in all age groups, followed by acquired non-infective non-traumatic causes, especially in the middle aged and elderly population. In the latter the most common individual diagnosis was joint problems (9% of MSI diagnoses). The Global Burden of Disease Study 2015 estimated that the most important contributors to global years lived with disability were musculoskeletal disorders (18.5%) [30]. Neck and Lower back pain were estimated in 2013 as the leading cause of years lived with disability in Cameroon [31]. The prevalence of MSI was shown to be increasing with age in our study. This finding supports studies of older person’s health in Botswana and Malawi that showed an increased probability of musculoskeletal disease and functional limitations [29, 32]. As the prevalence of musculoskeletal disorders increases with age, there will be a significant increase in requirements for health care and community support in the future.

Musculoskeletal disease is known to be a major cause of morbidity and mortality, especially in LICs with non-traumatic musculoskeletal disease estimated to account for 6.8% of all Disability-Adjusted Life Years (DALY) lost [1]. The overall prevalence of MSI in this study is almost double the 5.2% reported in Rwanda [8], but similar to the 11.6% reported in Fundong District, North-West Cameroon which used the same survey methods. The proportion of severe MSI was much higher in this study compared to what has been reported in Cameroon (2.4%) and Rwanda (8.4%). The reasons for this are unclear, but may, in part, reflect the long distances patients need to walk to seek medical attention in Malawi [33], and also the lack of medical expertise and equipment in the district hospitals and in the country overall. A study conducted by The College of Surgeons of East, Central, and Southern Africa (COSECSA) in 267 hospitals in east central and southern Africa has shown that current capacity to treat trauma and orthopaedic conditions is very limited, with particular areas of concern being manpower, training, facilities, and equipment [34]. However, the assessment of severe MSI deserves further attention in future studies.

Prosthetic and orthotic devices (P&O), physical therapy (rehabilitation), mobility aids, medication and surgery were the most frequently recommended treatments for the people identified with MSI in this study. These data have shown a significant treatment need for MSI in Malawi. With estimated 42,000 surgical operations needed, and only 11 orthopaedic surgeons in the country, it is obvious that Malawi is in dire need of scaling up surgical services rapidly and this concurred with the COSECSA study [34]. Some participants were very sick and there was no appropriate treatment to offer in our setting. However, counseling was provided to them and their relatives.

The burden of MSI is predicted to increase as the population of Malawi, and the World, is aging. Musculoskeletal impairment or disability related to trauma are also rapidly increasing in the future due to the rise in Road Traffic Injuries in our country [35] and worldwide [30]. Therefore, there is a need to recognize musculoskeletal conditions as a national and global public health priority. Solutions to fill this health service gap are needed. With the prevalence of MSI being higher among people living in rural areas, access to health services may be encouraged through health programs and support in rural communities. A wide range of ergonomically designed tools could be made available to ease agricultural work for those in need of this. Developing programs that serve populations at the district level [36], where needs can be assessed, and resources identified, may improve access to preventive services and rehabilitation, and facilitate transfer to tertiary hospitals when needed. Continued support of task shifting through the orthopaedic clinical officer program [37] at the district level is a natural part of this until a sufficient number of surgeons have been trained. However, to rapidly scale up the surgical specialist service in a severely resource limited country like Malawi, specialist services need to be concentrated to a few training centres while these grow into sustainably sized units. These units can scale up production more rapidly at lower investment costs and provide short stay trauma and orthopaedic services that serve the districts until enough surgeons can be trained also for the district hospitals.

This population-based survey used a standardized examination protocol to provide estimates of musculoskeletal impairment in the country. The data from this study provides important information to assist planning of P&O services, provision of mobility aids, rehabilitation, medical, and surgical services for persons with MSI in Malawi. The need for medical services such as surgery, drug supply, and rehabilitation has been be estimated, and the more detailed need for equipment and other assistive devices (e.g. appliances, orthoses, prostheses and wheelchairs) can be estimated from this information.

This study did have some limitations on the probability proportional to size sampling; diagnostic tools were limited to history and clinical examination, which restricted the identification of conditions that need complex investigations and data on other socioeconomic factors like occupational status/ type of occupation were not collected. Due to the long distances in some areas, the call back at a few households where people were unavailable was not achieved. Our demographic data were very limited. However, this study was a nationwide survey with a representative sample of people of all ages who were enumerated and examined. The response rate was high, and the sample was representative of the national population for both age and gender. This has reduced the likelihood of selection bias. The outcome definition was undertaken by well-trained medical students, using an examination protocol and screening tool, which was used in a similar study in Rwanda [21]. The inter-observer agreement between the data collectors was high as all were closely monitored and supervised.

Conclusion

This study has uncovered a high prevalence of MSI in Malawi and contributed data to the epidemiology of MSI nationally and globally. The Quality of Life of those with severe MSI was considerably affected. Increasing age and lack of formal education were factors that were associated with an increased risk of having MSI. The huge burden of musculoskeletal impairment in Malawi is mostly unattended, revealing an urgent need to scale up orthotics & prosthetics, physical & occupational therapy and surgical services in the country.

Supporting information

S1 File. Rapid assessment of Musculoskeletal impairment.

(PDF)

S2 File. Rapid assessment of Musculoskeletal impairment.

(PDF)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This study was funded by Norad through the Norhed programme. However the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Elliott Iains S., Groen Reinou S., Kamara Thaim B., Ertl Allison, Cassidy Laura D., Kushner Adam L., et al. The Burden of Musculoskeletal Disease in Sierra Leone. Clin orthop Relat Res (2015) 473:380–389; 10.1007/s11999-014-4017-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organisation (2001) International Classification of Functioning disability and Health. Geneva: World Health Organisation. [Google Scholar]
  • 3.The United Nations, Convention of the Rights of Persons with Disabilities and Optional Protocol. New York: United Nations; 2006. [Google Scholar]
  • 4.Biritwum RB, Devres JP, Ofosu-Amaah S, Marfo C, Essah ER (2001) Prevalence of children with disabilities in central region, Ghana. West Afr J Med 20: 249–255. [PubMed] [Google Scholar]
  • 5.Tamrat G, Kebede Y, Alemu S, Moore J (2001) The prevalence and characteristics of physical and sensory disabilities in Northern Ethiopia. Disabil Rehabil 23: 799–804. 10.1080/09638280110066271 [DOI] [PubMed] [Google Scholar]
  • 6.World Health Organisation (2002) Disability and Rehabilitation: Future Trends and Challenges in Rehabilitation. Geneva: World Health Organisation [Google Scholar]
  • 7.Helander E (1999) Prejudice and Dignity: an introduction to Community Based Rehabilitation. New York: UNDP. [Google Scholar]
  • 8.Atijosan O., et al. , A national survey of musculoskeletal impairment in Rwanda: prevalence, causes and service implications. PLoS One, 2008. 3(7): p. e2851 10.1371/journal.pone.0002851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Peden M, Scurfield R, Sleet D, Mohan D, Hyder A A. Jarawan E, et al. World report on road traffic injury prevention. 2004. http://apps.who.int/iris/bitstream/ 10665/42871/1/9241562609.pdf. Accessed 2016 Jul 20. [Google Scholar]
  • 10.Spiegel DA, Gosselin RA, Coughlin RR, Joshipura M, Browner BD, Dormans JP. The burden of musculoskeletal injury in low and middle-income countries: challenges and opportunities. J Bone Joint Surg Am. 2008. April;90(4):915–23. 10.2106/JBJS.G.00637 [DOI] [PubMed] [Google Scholar]
  • 11.Elliott IS, Groen RS, Kamara TB, Ertl A, Cassidy LD, Kushner AL, et al. The burden of musculoskeletal disease in Sierra Leone. Clin Orthop Relat Res. 2015. January;473(1):380–9. Epub 2014 Oct 25. 10.1007/s11999-014-4017-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kobusingye O, Guwatudde D, Lett R. Injury patterns in rural and urban Uganda. Inj Prev. 2001;7:46–50. 10.1136/ip.7.1.46 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Daar AS, Rizvi SA, Naqvi SA. Surgery with limited resources In: Morris PJ, Wood WC, editors. Oxford textbook of surgery. 2nd ed New York: Oxford University Press; 2000. p 3386. [Google Scholar]
  • 14.Atijosan O, Rischewski D, Simms V, Kuper H, Lavy C. The Orthopaedic Needs of Children in Rwanda: Results from a National Survey and Orthopaedic Service Implications. J Pediatr orthop 2009; 29:-951 10.1097/BPO.0b013e3181c18962 [DOI] [PubMed] [Google Scholar]
  • 15.Smythe T, Mactaggart I, Kuper H, Oye J, Sieyen N.C, Lavy C et al. Prevalence and causes of musculoskeletal impairment in Fundong District, North-West Cameroon: results of a population-based survey. Tropical Medicine and International Health. Vol. 22 no 11 pp 1385–1393, November 2017. 10.1111/tmi.12971 [DOI] [PubMed] [Google Scholar]
  • 16.Tataryn M., Polack S., Chokotho L., Mulwafu W., Kayange P., Banks L. M., et al. (2017). Childhood disability in Malawi: a population based assessment using the key informant method. BMC Pediatrics, 17(1), 198 10.1186/s12887-017-0948-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Alavi Y., Jumbe V., Hartley S., Smith S., Lamping D., Muhit M., et al. (2012). Indignity, exclusion, pain and hunger: the impact of musculoskeletal impairments in the lives of children in Malawi. Disability and Rehabilitation, 34(20), 1736–1746. 10.3109/09638288.2012.662260 [DOI] [PubMed] [Google Scholar]
  • 18.Varela Carlos, Young Sven, Groen Reinou, Banza Leonard, Mkandawire Nyengo C., Viste Asgaut. Untreated surgical conditions in Malawi: A randomised cross-sectional nationwide household survey. Malawi Medical Journal 29 (3):231–236 September 2017. 10.4314/mmj.v29i3.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Makaula Peter, Bloch Paul, Banda Hastings T, Mbera Grace Bongololo, Mangani Charles, Alexandra de Sousa, et al. Primary health care in rural Malawi—a qualitative assessment exploring the relevance of the community-directed interventions approach. BMC Health Services Research 2012, 12:328 10.1186/1472-6963-12-328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.http://unstats.un.org/unsd/demographic/meetings/egm/Sampling_1203/docs/no_2.pdf
  • 21.Atijosan O, Kuper H, Rischewski D, Simms V, Lavy C (2007) Musculoskeletal impairment survey in Rwanda: Design of survey tool, survey methodology, and results of pilot study (a cross sectional survey) BMC Musculoskeletal Disorders 8: 30 10.1186/1471-2474-8-30 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chopra A (2004) COPCORD—an unrecognised fountainhead of community rheumatology in developing countries. J Rheumatol 31: 2320–2321. [PubMed] [Google Scholar]
  • 23.Chokotho L., Mkandawire N., Conway D., Wu H.-H., Shearer D. D., Hallan G., et al. (2017). Validation and reliability of the Chichewa translation of the EQ-5D quality of life questionnaire in adults with orthopaedic injuries in Malawi. Malawi Medical Journal: The Journal of Medical Association of Malawi, 29(2), 84–88. 10.4314/mmj.v29i2.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.EuroQol: EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199–208. 10.1016/0168-8510(90)90421-9 [DOI] [PubMed] [Google Scholar]
  • 25.Jelsma J, Mhundwa K, Weerdt W De, Cock P De, Chimera J, Chivaura V: The reliability of the Shona version of the EQ-5 D. Central African Journal of Medicine 2001, 47:8–11. [DOI] [PubMed] [Google Scholar]
  • 26.Jelsma J, Chivaura V, De Cock P, De Weerdt W: A bridge between cultures: A report on the process of translating the EQ-5D instrument into Shona. South African Journal of Physiotherapy 2000,56:3–9. [Google Scholar]
  • 27.Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. The Lancet 2015. April 28, Vol. 386, No. 9993, p569–624 [DOI] [PubMed] [Google Scholar]
  • 28.World Bank.2017. “The High Toll of Traffic Injuries: Unacceptable and Preventable. © World Bank”
  • 29.Payne CF, Mkandawire J, Kohler HP. Disability transitions and health expectancies among adults 45 years and older in Malawi: a cohort-based model. PLoS Med 2013: 10: e1001435 10.1371/journal.pmed.1001435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disabil- ity for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015: 386: 743–800. 10.1016/S0140-6736(15)60692-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Collaborators GBoD. Global, regional, and national inci- dence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016: 388: 1545–1602. 10.1016/S0140-6736(16)31678-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Clausen T, Romoren TI, Ferreira M, Kristensen P, Ingstad B, Holmboe-Ottesen G. Chronic diseases and health inequal- ities in older persons in Botswana (southern Africa): a national survey. J Nutr Health Aging 2005: 9: 455–461. [PubMed] [Google Scholar]
  • 33.Varela C., Young S., Mkandawire N., Groen R. S., Banza L., & Viste A. (2019). Transportation barriers to access health care for surgical conditions in Malawi a cross sectional nationwide household survey. BMC Public Health, 19(1), 264 10.1186/s12889-019-6577-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chokotho L, Jacobsen KH, Burgess D, Labib M, Le G, Lavy CB, et al. Trauma and orthopaedic capacity of 267 hospitals in east central and southern Africa. Lancet. 2015. April 27;385 Suppl 2:S17 10.1016/S0140-6736(15)60812-1 Epub 2015 Apr 26. . [DOI] [PubMed] [Google Scholar]
  • 35.Banza L, Gallaher J, Dybvik E, Charles A, Hallan G, Gjertsen J.E, et al. The rise in road traffic injuries in Lilongwe, Malawi. A snapshot of the growing epidemic of trauma in low income countries. International Journal of Surgery Open 10 (2018) 1e6. [Google Scholar]
  • 36.Cook C, Qureshi B. VISION 2020 at the district level. Commun Eye Health 2005: 18: 85–89. [PMC free article] [PubMed] [Google Scholar]
  • 37.Mkandawire N., Ngulube C., & Lavy C. (2008). Orthopaedic clinical officer program in Malawi: a model for providing orthopaedic care. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Subas Neupane

10 May 2020

PONE-D-20-05125

Prevalence, Causes and Impact of Musculoskeletal Impairment in Malawi: A National Cluster Randomized Survey

PLOS ONE

Dear Dr Ngoie,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jun 24 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Subas Neupane

Academic Editor

PLOS ONE

Additional Editor Comments:

I agree with the reviewers suggestions to improve the quality of the manuscript. Please answer each of the reviews's questions carefully and revise the manuscript accordingly. I have here listed some additional comments.

Although the study title claimed that it is cluster randomized trial, but the methodology needs a lot of improvements to reflect the study design. The analysis should also take into account the study design it means that the data must be weighted.

The aim of the study is not very clear both in the abstract and in the main texts.

Introduction should present well the rationale of the study.

Methods need some more information on how the outcome was defined and measured, briefly about the main statistical technique used for the analysis etc. There are many errors and typos in the results, which should be corrected.

Explain, why only very limited demographic data are presented. Did author measure only these sets of variables? As such it is very limited and many details are lacking.

Statistical analysis part needs some more information as also pointed out by reviewer 2.

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1.    Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We noticed you have some minor occurrence of overlapping text with the following previous publication, which needs to be addressed:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483936/?amp=&tool=pubmed

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified how verbal consent was documented and witnessed). As your study included minors, please state whether you obtained consent from parents or guardians.

4. Please refer to any post-hoc corrections to correct for multiple comparisons during your statistical analyses. If these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting).

5. Please amend your authorship list in your manuscript file to include author Leonard Banza Ngoie.

6. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: There are too few studies on the burden of diseases from low income countries. World vide there is especially a lack of studies concerning musculoskeletal disorders. This manuscript is very interesting and very well written on this important topic. The study design is proper and the high response rate is remarkable (97%) and ending in a high number of participants (8548) in all ages. This is partly due to a relevant sampling method from survey field teams going from household to household. The method part is very well described in the text. The results are interesting and mostly clearly written, including both tables and a figure. One question is why do you come up with MSI according to ICF only as in the first sentence of the discussion? The ICF classification is important and could be showed and explained, more than just in appendices, in both methods and as a part of the results. The discussion is mostly on care and rehabilitation but could also include plausable causes for the MSI and aspects of prevention. E.g. most of the participants are living in rural areas and I suppose they work mostly with agricultural tasks. These are mostly one important cause to musculoskeletal problems world vide and one important method of prevention is ergonomics (physical). Training of physicians and other health care workers in simply ergonomics may be an important part of prevention, but this is, of course, not the main aim of this study.

Reviewer #2: Manuscript PONE-D-20-05125 entitled “Prevalence, Causes and Impact of Musculoskeletal Impairment in Malawi: A National Cluster Randomized Survey”

The work has covered an important issue of musculoskeletal impairment in one of the African country where this kind of research are limited. This survey report nicely reflect the musculoskeletal health of the people there. I would like to suggest the authors to address the changes according to the comments listed below:-

Overall, the manuscript has several qualities; however, there are several areas to be improved in the manuscript. The most important concern from my side is on methods part: some information is missing (example explanation of variables).

Abstract: The abstract looks good, has explained, and expressed much. In result ….. the

prevalence of MSI increased with age, and was similar in men (9·3%) and women (96%), check the %. Further, in conclusion some statements used are very irrelevant (second line)

Introduction: Introduction is wisely written. However, the authors shall be consistent in using the terms, for instance, musculoskeletal impairments have been studied and they have introduced the terms musculoskeletal diseases quite often.

*More focus should be given to impairments rather than disease or disorder.

*Second paragraph does not fit here, which, could have been more wisely used to connect with the outcome of the study.

*Or it would be better to state that musculoskeletal impairment includes disease, disorder, disability…..

*The authors could more explicitly state early on what were the major results/findings of several surveys of physical disability (as they have stated few were done) that were done before in Malawi.

*In the present form, the introduction is difficult to follow and missing some connection, please revise it thoroughly.

Methods: Though author have tried best to explain methods precisely. Explanation of variable and their construction are missing in some instances….

*Please explain more about EQ-5D-3L in this section, referring is not enough. Likewise, description of mild, moderate and severe MSI is missing.

*In case of sample size calculation (please give the values as *n= (84·5) (1- 0·054)/(0·054) (1.0) and could you please recheck that you have used a sample design effect of 2·0…

* Some form of cluster sampling used in the sample design of household surveys will help in reduction of cost and besides that, there are many other pros of cluster sampling in itself. However, the use of probability proportional to size sampling to select the clusters could permit the sampler to exercise greater control over the ultimate sample size or overall sample size. In addition, it could decrease the reliability of the sample because people living in the same cluster could be homogeneous or have the same background/ characteristics (clustering effect) and mostly this effect is balanced or compensated in the sample design by increasing the sample size accordingly. Did the authors experience this situation and applied some solution? if not it could be briefly noted on limitations part.

*Sub heading Screening for musculoskeletal impairment: …. “ This screening tool was developed by orthopaedic surgeons together with physiotherapists and has been shown to have 99% sensitivity and 97% specificity with interobserver Kappa scores of 0·90 for the diagnostic group……” It is quite surprising for me, how an interview/ a self-reported response on seven questions had such a profound level of sensitivity and specificity…. did author check for some bias, if there were any?

*Please rewrite the statistical analysis part, open up about the approaches used. Please ELABORATE

Results: Result section is easy to follow.

* Was the data on other socioeconomic factors like occupational status/ type of occupation collected? It would be more relevant to see the results (if available)

*Avoid the use of p-values in table 3, 95% CI is sufficient

* In table 3, age and sex adjusted estimates (ORs and 95% CIs) is confusing, is it so that OR and 95% CI for age was adjusted by gender, location, and educational level; for gender was adjusted by age, location and edu level…and so on?

* Use gender instead of sex, if it is reported as “gender” on first column

*Check the misprinting in table 4

*Again I would suggest that the explanation of EQ-5D index score calculation and extrapolation is important. It will help readers (easy to follow the results).

Discussion: There discussion has a logical presentation of results and comparison in the global and local scenario.

* The authors switch between the discussions of findings. Please discuss more from the point of age, gender and educational differences.

* “The burden of MSI is predicted to increase as the population of Malawi, and the World, is aging. Musculoskeletal impairment or disability related to trauma are also rapidly increasing in the future due to the rise in Road Traffic Injuries in our country31 and worldwide.23,27 Therefore, there is a need to recognize musculoskeletal conditions as a national and global public health priority. Solutions to fill this health service gap are needed. With the prevalence of MSI being higher among people living in rural areas, access to health services may be encouraged through health programs and support in rural communities…….” ..Here two very different scenarios are described together, …please mention these two circumstances separately ….

* “This population-based survey used a standardized examination protocol to provide estimates of musculoskeletal impairment in the country. The data from this study provide important information to assist planning of P&O devices, mobility aids, rehabilitation, medical, and surgical services for persons with MSI in Malawi. For example, the need for medical services such as surgery, drug supply, and rehabilitation can be estimated, and the need for equipment and other assistive devices (e.g. appliances, orthoses, prostheses and wheelchairs) can also be estimated from this information. Therefore, production and supply of these items can be anticipated. Medical services can be used to measure the capacity of existing services in the country, for advocacy and planning of future service provision such as training of both paramedical and medical personnel (e.g. surgeons, prosthetists & orthotists, physical therapists), building of new health care facilities or improving the existing ones to treat the burden of MSI.”………… For me this is little ambitious. In my opinion, this is certainly a broad piece of work that is carried out with precision plus methodological qualities; however, there are still some gaps in the survey that could be fulfilled.

*Please separately specify the strengths and weakness of the study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jan 6;16(1):e0243536. doi: 10.1371/journal.pone.0243536.r002

Author response to Decision Letter 0


20 Oct 2020

Dear Editor,

Thank you for the opportunity to resubmit this article after revisions, and for extending the deadline due to the Covid-19 situation in Malawi and elsewhere. The authors apologise for the very late resubmission. This is due to the dire situation over the last few months in Malawi after Covid-19 hit the country. The situation is slowly recovering but the backlog of surgical patients is huge.

We do believe that this study has uncovered some dramatic information about the burden of disabilities in Malawi that really needs to be communicated, and hope you will now find the manuscript worthy of publication in PLOS ONE. We thank you and the reviewers for your time and efforts to provide helpful comments, and have tried to address all these below and through the revisions in the manuscript:

Although the study title claimed that it is cluster randomized trial, but the methodology needs a lot of improvements to reflect the study design. The analysis should also take into account the study design it means that the data must be weighted.

Thank you. We agree that analysis should be weighted, but data on population according to the clusters in Malawi was not possible to obtain.

The aim of the study is not very clear both in the abstract and in the main texts.

We agree this might have been presented more clearly and have edited the text. We hope it is now clearer.

Introduction should present well the rationale of the study.

Thank you for pointing this out. We have revised the introduction and hope it is clearer now.

Methods need some more information on how the outcome was defined and measured, briefly about the main statistical technique used for the analysis etc. There are many errors and typos in the results, which should be corrected.

We have in the revised manuscript made changes in the text to clarify this, and errors have been corrected to our best ability. We hope that the presentation now is acceptable to your journal.

Explain, why only very limited demographic data are presented. Did author measure only these sets of variables? As such it is very limited and many details are lacking.

The data that is presented was the only demographic data measured. The data included age, gender, location of settlement and educational level. Similar studies also have had a limited set of demographic data. A survey of this scale and design is a huge logistic exercise anywhere, but in a resource limited environment like Malawi even more so, and there needs to be a balance between the desire for comprehensive information and time and funding limitations. We believe the presented demographics include the essentials, but of course, a more comprehensive set of data would have been better. The scarcity of details has now been acknowledged as a study limitation in the appropriate section of our manuscript.

Statistical analysis part needs some more information as also pointed out by reviewer 2.

Thank you. This section has been revisited with the second author (ED) who is a bio statistician with the Norwegian Arthroplasty Register.

3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified how verbal consent was documented and witnessed). As your study included minors, please state whether you obtained consent from parents or guardians.

Consent forms were used. Both verbal and written Consent was obtained from adults (18 years of age and above), and assent was obtained from parents/guardians of children less than 18 years of age. This has now been described in the ethical approval section.

4. Please refer to any post-hoc corrections to correct for multiple comparisons during your statistical analyses. If these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting).

Since no multiple comparisons were done, post hoc correction was not relevant here.

5. Please amend your authorship list in your manuscript file to include author Leonard Banza Ngoie.

Thank you for noticing this accidental omission. The author list now includes Leonard Banza Ngoie

6. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure.

Reference to Figure 1 has been included.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Changes have been made (see Methods and Appendix sections)

Reviewer #1:

One question is why do you come up with MSI according to ICF only as in the first sentence of the discussion?

The ICF classification is important and could be showed and explained, more than just in appendices, in both methods and as a part of the results.

We agree that the ICF classification should have been included earlier in the manuscript. In the revised manuscript the ICF classification has been explained in the Methods.

The discussion is mostly on care and rehabilitation but could also include plausible causes for the MSI and aspects of prevention. E.g. most of the participants are living in rural areas and I suppose they work mostly with agricultural tasks. These are mostly one important cause to musculoskeletal problems world vide and one important method of prevention is ergonomics (physical). Training of physicians and other health care workers in simply ergonomics may be an important part of prevention, but this is, of course, not the main aim of this study.

This is a good point. We have added a comment on this in the text.

(see paragraph 6 of the discussion section)

Reviewer #2:

Overall, the manuscript has several qualities; however, there are several areas to be improved in the manuscript. The most important concern from my side is on methods part: some information is missing (example explanation of variables).

Thank you for pointing this out. We agree, and the methods section has been revised.

Abstract: The abstract looks good, has explained, and expressed much. In result ….. the

prevalence of MSI increased with age, and was similar in men (9·3%) and women (96%), check the %.

Thank you for noticing this. Checked and corrected.

Further, in conclusion some statements used are very irrelevant (second line)

We agree. These irrelevant statements have been removed.

Introduction: Introduction is wisely written. However, the authors shall be consistent in using the terms, for instance, musculoskeletal impairments have been studied and they have introduced the terms musculoskeletal diseases quite often.

*More focus should be given to impairments rather than disease or disorder.

*Or it would be better to state that musculoskeletal impairment includes disease, disorder, disability…..

We agree that there was some inconsistency here and have tried to remedy this in the revised manuscript.

*Second paragraph does not fit here, which, could have been more wisely used to connect with the outcome of the study.

Another good point. Changes have been made.

*The authors could more explicitly state early on what were the major results/findings of several surveys of physical disability (as they have stated few were done) that were done before in Malawi.

We have attempted to clarify this in the introduction, although most of these studies were based on physical disability in general.

*In the present form, the introduction is difficult to follow and missing some connection, please revise it thoroughly.

The introduction has been revised. We hope it is clearer now.

Methods: Though author have tried best to explain methods precisely. Explanation of variable and their construction are missing in some instances….

*Please explain more about EQ-5D-3L in this section, referring is not enough. Likewise, description of mild, moderate and severe MSI is missing.

Changes have been made. A new section on EQ-5D-3L has been inserted in Methods. Also, a definition of mild, moderate and severe MSI has been added.

*In case of sample size calculation (please give the values as *n= (84·5) (1- 0·054)/(0·054) (1.0) and could you please recheck that you have used a sample design effect of 2·0…

When focusing on household survey sample size, in terms of households it was calculated using the formula: nh = (z 2 ) (r) (1-r) (f) (k)/ (p) (n) (e 2 )

The reference quoted recommends parameters as follows: z-statistics should be 1.96 for 95-percent level of confidence, as default value of f (sample design effect) should be set at 2.0 since there is no empirical data from previous or related surveys, k is multiplier to account for anticipated rate of non-responders, a value of 1.1 would be a conservative choice for a undeveloped country as Malawi. Average household size is given by n, and margin of error to be attained is denoted by e, which is recommended to set as 10 percent of r, e=0.10r.

nh = (3.84) (1-r) (1.2) (1.1)/ (r) (p) (6) (.01)

reduced to

nh = (84.5) (1-r)/ (r) (p)

where r is an estimate of a key indicator in the survey and p is proportion of the total population accounted for by the target population.

nh = (84.5) (1-0.054)/ (0.054) (1.0) = 1,481

* Some form of cluster sampling used in the sample design of household surveys will help in reduction of cost and besides that, there are many other pros of cluster sampling in itself. However, the use of probability proportional to size sampling to select the clusters could permit the sampler to exercise greater control over the ultimate sample size or overall sample size. In addition, it could decrease the reliability of the sample because people living in the same cluster could be homogeneous or have the same background/ characteristics (clustering effect) and mostly this effect is balanced or compensated in the sample design by increasing the sample size accordingly. Did the authors experience this situation and applied some solution? if not it could be briefly noted on limitations part.

Thank you. Limitation of probability proportional to size sampling has now been mentioned in the discussion (last paragraph).

*Sub heading Screening for musculoskeletal impairment: …. “ This screening tool was developed by orthopaedic surgeons together with physiotherapists and has been shown to have 99% sensitivity and 97% specificity with interobserver Kappa scores of 0·90 for the diagnostic group……” It is quite surprising for me, how an interview/ a self-reported response on seven questions had such a profound level of sensitivity and specificity…. did author check for some bias, if there were any?

This statement is referenced in the manuscript and refers to the paper by Atijosan et al (2007) where the tool was validated. The tool was developed and published together with recognised scholars from the University of Oxford and London School of Hygiene and Tropical Medicine, and we have accepted the findings as presented in their work.

*Please rewrite the statistical analysis part, open up about the approaches used. Please ELABORATE

The statistics section has been revised with our bio statistician co-author (ED).

Results: Result section is easy to follow.

* Was the data on other socioeconomic factors like occupational status/ type of occupation collected? It would be more relevant to see the results (if available)

This was not the main aim of this study. We agree that would be relevant but unfortunately this information was not available.

*Avoid the use of p-values in table 3, 95% CI is sufficient

Corrected. P-values have been removed from table 3 (now table 4)

* In table 3, age and sex adjusted estimates (ORs and 95% CIs) is confusing, is it so that OR and 95% CI for age was adjusted by gender, location, and educational level; for gender was adjusted by age, location and edu level…and so on?

We used logistic regression analyses meaning that the OR is adjusted for in the way you describe above. This has been described in the Statistics paragraph and in the table text for Table 3 (now table 4).

* Use gender instead of sex, if it is reported as “gender” on first column

Corrected

*Check the misprinting in table 4

Corrected (now table 5)

*Again I would suggest that the explanation of EQ-5D index score calculation and extrapolation is important. It will help readers (easy to follow the results).

Changes have been made (“screening for musculoskeletal impairment” section).

Discussion: There discussion has a logical presentation of results and comparison in the global and local scenario.

* The authors switch between the discussions of findings. Please discuss more from the point of age, gender and educational differences.

We have made some changes in the discussion section to accommodate this point. Please see paragraph 2.

* “The burden of MSI is predicted to increase as the population of Malawi, and the World, is aging. Musculoskeletal impairment or disability related to trauma are also rapidly increasing in the future due to the rise in Road Traffic Injuries in our country31 and worldwide.23,27 Therefore, there is a need to recognize musculoskeletal conditions as a national and global public health priority. Solutions to fill this health service gap are needed. With the prevalence of MSI being higher among people living in rural areas, access to health services may be encouraged through health programs and support in rural communities…….” ..Here two very different scenarios are described together, …please mention these two circumstances separately ….

Thanks for the observation. We have dealt with the two circumstances separately in the discussion section (paragraph 6).

* “This population-based survey used a standardized examination protocol to provide estimates of musculoskeletal impairment in the country. The data from this study provide important information to assist planning of P&O devices, mobility aids, rehabilitation, medical, and surgical services for persons with MSI in Malawi. For example, the need for medical services such as surgery, drug supply, and rehabilitation can be estimated, and the need for equipment and other assistive devices (e.g. appliances, orthoses, prostheses and wheelchairs) can also be estimated from this information. Therefore, production and supply of these items can be anticipated. Medical services can be used to measure the capacity of existing services in the country, for advocacy and planning of future service provision such as training of both paramedical and medical personnel (e.g. surgeons, prosthetists & orthotists, physical therapists), building of new health care facilities or improving the existing ones to treat the burden of MSI.”………… For me this is little ambitious. In my opinion, this is certainly a broad piece of work that is carried out with precision plus methodological qualities; however, there are still some gaps in the survey that could be fulfilled.

We do agree with this observation, however, this is what we were able to achieve at our level best. Some of the mentioned gaps are among the study’s weaknesses. Despite this, we do believe this study brings forward very important information for policy makers in Malawi, and regionally and that some of the gaps are areas for potential future research.

*Please separately specify the strengths and weakness of the study.

We have made the suggested changes in the revised manuscript.

Thank you again for the opportunity to resubmit this manuscript and many thanks to the reviewers for their helpful feedback.

Best regards

Leonard Banza

Attachment

Submitted filename: MSI Response To Reviewers.docx

Decision Letter 1

Subas Neupane

10 Nov 2020

PONE-D-20-05125R1

Prevalence, Causes and Impact of Musculoskeletal Impairment in Malawi: A National Cluster Randomized Survey

PLOS ONE

Dear Dr. Ngoie,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: In abstract, the methods part, please explain briefly how the study subjects were randomized and how musculoskeletal impairments were measured in ICF criteria and the main statistical methods used to analyze the data.

==============================

Please submit your revised manuscript by Dec 25 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Subas Neupane

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Thank you for the revised manuscript. Both the reviewer are happy with the revision the authors have made. I have now only few minor issues in the manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors has noted my comments in the methods and discussion and changed the text accordingly to an acceptable extent

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jan 6;16(1):e0243536. doi: 10.1371/journal.pone.0243536.r004

Author response to Decision Letter 1


19 Nov 2020

Dear Editor,

Thank you for the opportunity to resubmit this article after revisions, following a brief feedback from you.

We thank you and the reviewers for your time and efforts to provide helpful comments, and have tried to address all these below and through the revisions in the manuscript:

ACADEMIC EDITOR: In abstract, the methods part, please explain briefly how the study subjects were randomized and how musculoskeletal impairments were measured in ICF criteria and the main statistical methods used to analyse the data.

The abstract has been completely revised and most of the points raised were addressed.

Thank you again for the opportunity to resubmit this manuscript and many thanks to the reviewers for their positive response to our previous manuscript.

Best regards

Leonard Banza

Attachment

Submitted filename: Response To Reviewers.docx

Decision Letter 2

Subas Neupane

24 Nov 2020

Prevalence, Causes and Impact of Musculoskeletal Impairment in Malawi: A National Cluster Randomized Survey

PONE-D-20-05125R2

Dear Dr. Ngoie,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Subas Neupane

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Subas Neupane

2 Dec 2020

PONE-D-20-05125R2

Prevalence, Causes and Impact of Musculoskeletal Impairment in Malawi: A National Cluster Randomized Survey

Dear Dr. Ngoie:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Subas Neupane

Guest Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Rapid assessment of Musculoskeletal impairment.

    (PDF)

    S2 File. Rapid assessment of Musculoskeletal impairment.

    (PDF)

    Attachment

    Submitted filename: MSI Response To Reviewers.docx

    Attachment

    Submitted filename: Response To Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES